Truqap is really a kinase inhibitor that works by blocking pathways that support the cancer cells survive and expand, so lowers cancer growth. Truqap is from a category of medicines termed an AKT inhibitor. Truqap received FDA acceptance on November 17, 2023, right after optimistic benefits in the CAPItello-291 Phase https://franciscoxjvhr.nizarblog.com/34959270/the-definitive-guide-to-pentiapine